Citigroup’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.61K | Sell |
3,115
-26,721
| -90% | -$31K | ﹤0.01% | 4571 |
|
|
2025
Q1 | $32.8K | Sell |
29,836
-50,509
| -63% | -$55.6K | ﹤0.01% | 4220 |
|
|
2024
Q4 | $138K | Buy |
80,345
+49,753
| +163% | +$85.6K | ﹤0.01% | 3822 |
|
|
2024
Q3 | $75.9K | Buy |
30,592
+21,177
| +225% | +$52.5K | ﹤0.01% | 4111 |
|
|
2024
Q2 | $22.8K | Sell |
9,415
-125,979
| -93% | -$305K | ﹤0.01% | 4229 |
|
|
2024
Q1 | $548K | Sell |
135,394
-12,417
| -8% | -$50.3K | ﹤0.01% | 2790 |
|
|
2023
Q4 | $568K | Buy |
147,811
+109,313
| +284% | +$420K | ﹤0.01% | 2599 |
|
|
2023
Q3 | $160K | Buy |
38,498
+37,801
| +5,423% | +$157K | ﹤0.01% | 3084 |
|
|
2023
Q2 | $3.35K | Sell |
697
-40,680
| -98% | -$196K | ﹤0.01% | 4500 |
|
|
2023
Q1 | $168K | Sell |
41,377
-4,197
| -9% | -$17K | ﹤0.01% | 3205 |
|
|
2022
Q4 | $246K | Buy |
45,574
+37,258
| +448% | +$201K | ﹤0.01% | 2942 |
|
|
2022
Q3 | $83K | Buy |
8,316
+7,385
| +793% | +$73.7K | ﹤0.01% | 3469 |
|
|
2022
Q2 | $4K | Sell |
931
-2,762
| -75% | -$11.9K | ﹤0.01% | 4875 |
|
|
2022
Q1 | $14K | Sell |
3,693
-198
| -5% | -$751 | ﹤0.01% | 4586 |
|
|
2021
Q4 | $26K | Buy |
3,891
+2,797
| +256% | +$18.7K | ﹤0.01% | 4544 |
|
|
2021
Q3 | $16K | Buy |
+1,094
| New | +$16K | ﹤0.01% | 4561 |
|